UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells

Frontiers in immunology, 2024-08, Vol.15, p.1437224

2024

Volltextzugriff (PDF)

Interleukin 32, inflammation and cancer

Pharmacology & therapeutics (Oxford), 2017-06, Vol.174, p.127-137

2017

Volltextzugriff (PDF)

Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease

Frontiers in endocrinology (Lausanne), 2019-09, Vol.10, p.613-613

2019

Volltextzugriff (PDF)

Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production

FEBS letters, 2013-11, Vol.587 (23), p.3776-3781

2013

Volltextzugriff (PDF)

IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B

Journal of allergy and clinical immunology, 2020-07, Vol.146 (1), p.156-168

2020

Volltextzugriff (PDF)

PREGNANT WOMEN WITH COVID-19 AND PLACENTA ANGIOGENESIS

Polski merkuriusz lekarski, 2023, Vol.51 (5), p.441-447

2023

Volltextzugriff (PDF)

Vascular growth factors of the placenta, apoptosis of blood neutrophils in pregnant women with post-COVID syndrome

Reproduktivnaâ èndokrinologiâ, 2023-12 (70), p.23-26

2023

Volltextzugriff (PDF)

Comparison of the Seven Interleukin-32 Isoforms' Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity

Frontiers in immunology, 2022-02, Vol.13, p.837588-837588

2022

Volltextzugriff (PDF)

Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction

Frontiers in immunology, 2021-05, Vol.12, p.673061-673061

2021

Volltextzugriff (PDF)

Molecular mechanism–driven new biomarkers and therapies for atopic dermatitis

Journal of allergy and clinical immunology, 2020-07, Vol.146 (1), p.72-73

2020

Volltextzugriff (PDF)

Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells

BioFactors (Oxford), 2024-03, Vol.50 (2), p.294-310

2024

Volltextzugriff (PDF)

Role of interleukin-32 in the pathogenesis of endometriosis: in vitro, human and transgenic mouse data

Human reproduction (Oxford), 2018-05, Vol.33 (5), p.807-816

2018

Volltextzugriff (PDF)

Interleukin-32: Frenemy in cancer?

BMB reports, 2019-03, Vol.52 (3), p.165-174

2019

Volltextzugriff (PDF)

Increased levels of interleukin‐32 isoforms alpha, beta, gamma, and delta in the gingival crevicular fluid and plasma of the patients with periodontitis

Journal of periodontal research, 2021-01, Vol.56 (1), p.83-92

2021

Volltextzugriff (PDF)

Interleukin-32: Frenemy in cancer?

BMB Reports, 2019, 52(3), , pp.165-174

2019

Volltextzugriff (PDF)

Human IL-32θA94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin αVβ3 and αVβ6 in TNF-α-stimulated HUVECs

Frontiers in immunology, 2023, Vol.14, p.1160301

2023

Volltextzugriff (PDF)

Increased Salivary Cytokines and Nitric Oxide Levels in Behçet's Disease: Interleukin-32, a Novel Player in Disease Prognosis

Endocrine, metabolic & immune disorders drug targets, 2023-01, Vol.23 (3), p.347-355

2023

Volltextzugriff (PDF)

Enhanced neuroinflammatory responses after systemic LPS injection in IL-32β transgenic mice

Journal of chemical neuroanatomy, 2018-12, Vol.94, p.173-182

2018

Volltextzugriff (PDF)

Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association

International journal of molecular sciences, 2019-04, Vol.20 (8), p.1949

2019

Volltextzugriff (PDF)

Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2

Cancer letters, 2012-05, Vol.318 (2), p.226-233

2012

Volltextzugriff (PDF)

Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition

Journal of experimental & clinical cancer research, 2018-11, Vol.37 (1), p.293-16, Article 293

2018

Volltextzugriff (PDF)

Transgenic mice expressing human IL-32 develop adipokine profiles resembling those of obesity-induced metabolic changes

Cytokine (Philadelphia, Pa.), 2020-01, Vol.125, p.154793-154793, Article 154793

2020

Volltextzugriff (PDF)

Prognostic Value of Interleukin-32 Expression and Its Correlation with the Infiltration of Natural Killer Cells in Cutaneous Melanoma

Journal of clinical medicine, 2021-10, Vol.10 (20), p.4691

2021

Volltextzugriff (PDF)

Reducing Effect of IL-32α in the Development of Stroke Through Blocking of NF-κB, but Enhancement of STAT3 Pathways

Molecular neurobiology, 2015-04, Vol.51 (2), p.648-660

2015

Volltextzugriff (PDF)

Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells

OncoTargets and therapy, 2016-01, Vol.9, p.4225-4237

2016

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

ThemaIl-32

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Englisch
(40)
Koreanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells

Interleukin 32, inflammation and cancer

Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease

Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production

IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B

PREGNANT WOMEN WITH COVID-19 AND PLACENTA ANGIOGENESIS

Vascular growth factors of the placenta, apoptosis of blood neutrophils in pregnant women with post-COVID syndrome

Comparison of the Seven Interleukin-32 Isoforms' Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity

Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction

Molecular mechanism–driven new biomarkers and therapies for atopic dermatitis

Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells

Role of interleukin-32 in the pathogenesis of endometriosis: in vitro, human and transgenic mouse data

Interleukin-32: Frenemy in cancer?

Increased levels of interleukin‐32 isoforms alpha, beta, gamma, and delta in the gingival crevicular fluid and plasma of the patients with periodontitis

Interleukin-32: Frenemy in cancer?

Human IL-32θA94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin αVβ3 and αVβ6 in TNF-α-stimulated HUVECs

Increased Salivary Cytokines and Nitric Oxide Levels in Behçet's Disease: Interleukin-32, a Novel Player in Disease Prognosis

Enhanced neuroinflammatory responses after systemic LPS injection in IL-32β transgenic mice

Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association

Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2

Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition

Transgenic mice expressing human IL-32 develop adipokine profiles resembling those of obesity-induced metabolic changes

Prognostic Value of Interleukin-32 Expression and Its Correlation with the Infiltration of Natural Killer Cells in Cutaneous Melanoma

Reducing Effect of IL-32α in the Development of Stroke Through Blocking of NF-κB, but Enhancement of STAT3 Pathways

Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells

Aktive Filter

Suchergebnisse filtern